Technology · India Bureau
AI-assisted discovery identifies new gene-editing system with CRISPR-like potential
Researchers leveraging artificial intelligence have identified a novel gene-editing mechanism called ART, potentially expanding the toolkit for genetic modification. The discovery, validated through laboratory experiments, was made by scanning hundreds of thousands of genetic sequences in record time.
LSN India ·
Scientists have identified a previously unknown gene-editing system with capabilities comparable to CRISPR technology, marking a significant advance in genetic research tools. The system, designated ART, was discovered through a computational screening process that analyzed over 200,000 reverse transcriptase sequences in just 21 hours.
The identification process employed a large-scale computational approach, with nearly 1,000 AI agents systematically examining genetic databases to identify promising candidates for further study. This methodology proved considerably faster than traditional discovery approaches, demonstrating the potential efficiency gains from computational screening in molecular biology research.
Following the computational identification, researchers conducted laboratory validation experiments to confirm the system's functionality and gene-editing capabilities. The successful validation suggests ART could serve as an alternative or complementary tool to existing CRISPR systems, which have become central to modern genetic engineering applications.
The discovery underscores growing interest in harnessing artificial intelligence for accelerated scientific research. As CRISPR-based therapeutics advance toward clinical applications in treating genetic diseases, the identification of alternative gene-editing systems could provide researchers with expanded options for precision medicine approaches.
Gene-editing technologies remain of particular interest to the biomedical research community in South Asia, where applications in crop improvement and disease treatment could address regional health challenges. The broader availability of validated gene-editing tools may facilitate expanded research capabilities across the region.